ClinicalTrials.gg
TerminatedNCT01927575TOMOUpdated Jun 4, 2020Results posted

Pilot Study Comparing Diagnostic Imaging Versus Tomosynthesis in Detection of Hip, Wrist or Tibia Injury

An interventional study of Standard X-Ray + CT and Standard X-Ray + MRI in Wrist Injury, Tibial Fracture and Hip Injury, sponsored by Fujifilm Medical Systems USA, Inc.. Terminated at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-06-04.

Sponsored by Fujifilm Medical Systems USA, Inc. · Not applicable, Interventional, and Diagnostic

Why this study was terminated
Sponsor decision to close trial
Phase
Not applicable
Study type
Interventional
Enrollment
1
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

To acquire and build a library of image sets to determine if Fuji's TOMO imaging device can replace or compliment current imaging standards to assess patients with hip, wrist or tibia injuries.

Read the detailed description

Subjects presenting with a wrist injury, tibial fracture, or hip injury that require protocol defined standard imaging will have an X-Ray, CT Scan (or MRI per site preference) and TOMO completed. Images will be assessed to determine if TOMO is appropriate to supplement or replace the need for the other standard images.

02

Conditions studied

  • Wrist Injury
  • Tibial Fracture
  • Hip Injury

Keywords

  • TOMOSYNTHESIS
03

In context

Wrist Injuries

46 studies on the registry are indexed under Wrist Injuries; 12 are open to participants now.

This study's enrollment of 1 is below the median of 53 across 32 interventional studies indexed under Wrist Injuries.

Browse Wrist Injuries studies →

Lead sponsor

Fujifilm Medical Systems USA, Inc. is the lead sponsor of 14 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Physician request to have diagnostic imaging for condition areas

Exclusion criteria

Exclusion Criteria:

  • Under 18
  • Pregnancy
  • Insufficient Anatomical Coverage or Potential Image Problems
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
1 participant (actual)

Study arms

  • Active comparator
    Standard X-Ray + CT

    Standard X-Ray + CT arm to be used as comparative arm for investigational imaging device. Investigators will determine standard of care to be used on a per subject basis.

    Device: Standard X-Ray + CT · Device: TOMO

  • Active comparator
    Standard X-Ray + MRI

    Standard X-Ray + MRI arm to be used as comparative arm for investigational imaging device. Investigators will determine standard of care to be used on a per subject basis.

    Device: Standard X-Ray + MRI · Device: TOMO

  • Experimental
    Tomo

    Fujifilm Digital Radiographic AcSelerate CsI System with Tomosynthesis

    Device: Standard X-Ray + CT · Device: Standard X-Ray + MRI · Device: TOMO

Interventions

  • DeviceStandard X-Ray + CT

    Standard of Care X-Ray Imaging + CT

  • DeviceStandard X-Ray + MRI

    Standard of Care X-Ray Imaging + MRI

  • DeviceTOMO

    Fujifilm Digital Radiographic AcSelerate CsI System with Tomosynthesis

06

What researchers measure

Primary outcomes

  1. Number of Participants for Whom Tibia Injury Was Detected

    Clinical utility where the DTS could replace and/or complement existing imaging procedures; for example, Computed Tomography for fractures of the tibial plateau or scaphoid - where radiation dose, access to modality and cost play a factor in planning initial diagnosis and/or follow-up imaging strategies. Subsequent independent review by the principal investigator (PI) \[or designee\] to show the ability of the Fujifilm DTS system to provide images of clinical equivalence compared to those acquired on other FDA cleared imaging systems.

    Time frame: Baseline Imaging Collection

07

Results

Posted Jun 5, 2017

Participant flow

Subjects who present for, are undergoing, or have undergone 'standard of care' general x-ray and CT or MRI examinations, which meet all of the study enrollment criteria, may be approached and enrolled. Each subject would then have a 3rd image taken using Fujifilm's Digital Radiographic AcSelerate CsI System with Tomosynthesis.

Participant flow — Overall Study
MilestoneAll Study Participants
Started1
Completed1
Not completed0

Outcome measures

PrimaryNumber of Participants for Whom Tibia Injury Was Detected

Clinical utility where the DTS could replace and/or complement existing imaging procedures; for example, Computed Tomography for fractures of the tibial plateau or scaphoid - where radiation dose, access to modality and cost play a factor in planning initial diagnosis and/or follow-up imaging strategies. Subsequent independent review by the principal investigator (PI) \[or designee\] to show the ability of the Fujifilm DTS system to provide images of clinical equivalence compared to those acquired on other FDA cleared imaging systems.

Time frame:
Baseline Imaging Collection
Reported as:
Number · participants
Number of Participants for Whom Tibia Injury Was Detected
participantsStandard X-RayStandard CTTomosynthesis
Number of Participants for Whom Tibia Injury Was Detected111

Adverse events

Collected over 1 day; Standard of Care X-ray, CT and Tomo all completed within this day.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Standard X-Ray0/1 (0%)0/1 (0%)0/1 (0%)
Standard CT0/1 (0%)0/1 (0%)0/1 (0%)
Tomo0/1 (0%)0/1 (0%)0/1 (0%)

Baseline characteristics

1 patient was enrolled in this study, and they underwent Standard X-Ray and CT as well as Tomosynthesis.

Age, Categorical
Age, Categorical(Participants)All Study Participants
<=18 years0
Between 18 and 65 years1
>=65 years0
Age, Continuous
Age, Continuous(years)All Study Participants
Mean54 ± NA
Sex: Female, Male
Sex: Female, Male(Participants)All Study Participants
Female0
Male1
08

Study locations

1 site
  • Loyola University of Chicago
    Maywood, Illinois 60153, United States
09

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

10

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Sep 2013, a primary completion of Apr 2014 and a completion of Apr 2014. It does not say whether these dates are actual or estimated.

Results were first posted in Jun 2017, 3 years 2 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 20, 2013
First posted
Aug 22, 2013
Start
Sep 2013
Primary completionActual
Apr 2014
CompletionActual
Apr 2014
Results first posted
Jun 5, 2017
Last update
Jun 4, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 4, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01927575
Lead sponsor
Fujifilm Medical Systems USA, Inc.
Responsible party
Sponsor
First posted
Aug 22, 2013
Start date
Sep 2013
Primary completion
Apr 2014
Completion
Apr 2014
Results posted
Jun 5, 2017
Last update
Jun 4, 2020

Study contacts

Davide Bova, MD
principal investigator · Loyola University Chicago

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in May 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion